APREPITANT and PYREXIA

Overview

PYREXIA is the #3 most commonly reported adverse reaction for APREPITANT, manufactured by Merck Sharp & Dohme LLC. There are 1,589 FDA adverse event reports linking APREPITANT to PYREXIA. This represents approximately 2.2% of all 73,587 adverse event reports for this drug.

Patients taking APREPITANT who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA is a less commonly reported adverse event for APREPITANT, but still significant enough to appear in the safety profile.

Other Side Effects of APREPITANT

In addition to pyrexia, the following adverse reactions have been reported for APREPITANT:

• NAUSEA — 2,147 reports
• FATIGUE — 1,769 reports
• DIARRHOEA — 1,542 reports
• DYSPNOEA — 1,508 reports
• VOMITING — 1,474 reports
• OFF LABEL USE — 1,340 reports
• ALOPECIA — 1,274 reports
• RASH — 1,210 reports
• HYPERSENSITIVITY — 1,133 reports
• FEBRILE NEUTROPENIA — 1,045 reports

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

Does APREPITANT cause PYREXIA?

PYREXIA has been reported as an adverse event in 1,589 FDA reports for APREPITANT. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with APREPITANT?

PYREXIA accounts for approximately 2.2% of all adverse event reports for APREPITANT, making it one of the most commonly reported side effect.

What should I do if I experience PYREXIA while taking APREPITANT?

If you experience pyrexia while taking APREPITANT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages